Olga Ace
Impact in
- Oncology top 5%
- Inflammatory Biomarkers in Disease Prognosis
- Cancer Immunotherapy and Biomarkers
- Cancer Cells and Metastasis
- Lung Cancer Research Studies
- Pancreatic and Hepatic Oncology Research
- Cancer Research top 10%
- Cancer, Lipids, and Metabolism
Papers in
- Oncology 5
- Inflammatory Biomarkers in Disease Prognosis 2
- Cancer Immunotherapy and Biomarkers 2
- Cytokine Signaling Pathways and Interactions 1
-
- Cancer, Lipids, and Metabolism 2
- Cancer Genomics and Diagnostics 1
- Co-authors
- Francisco Vera-Badillo (4 shared papers)Eitan Amir (4 shared papers)Arnoud J. Templeton (4 shared papers)Alberto Ocaña (4 shared papers)Boštjan Šeruga (3 shared papers)Ian F. Tannock (3 shared papers)Thomas Hermanns (2 shared papers)Mustafa Al-Mubarak (2 shared papers)
In The Last Decade
Olga Ace
8 papers receiving 803 citations
Olga Ace's Hit Papers
Peers
Comparison fields: 5 of 80
- Oncology 573
- Cancer Research 174
- Immunology 139
- Biological Psychiatry 13
- Pulmonary and Respiratory Medicine 156
Countries citing papers authored by Olga Ace
This map shows the geographic impact of Olga Ace's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Olga Ace with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Olga Ace more than expected).
Fields of papers citing papers by Olga Ace
This network shows the impact of papers produced by Olga Ace. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Olga Ace. The network helps show where Olga Ace may publish in the future.
Co-authors
The 20 scholars most cited alongside Olga Ace, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Prognostic Role of Platelet to Lymphocyte Ratio in Solid Tumors: A Systematic Review and Meta-Analysis Hit paper breakdown → | 2014 | 546 |
| 2 | 2010 | 121 | |
| 3 | 2017 | 48 | |
| 4 | 2014 | 45 | |
| 5 | 2010 | 38 | |
| 6 | 2015 | 13 | |
| 7 | Myocarditis as the initial presentation of Epstein-Barr virus infection in a 17-year-old male patient. | 2019 | 4 |
| 8 | 2023 | 1 |
About Olga Ace
Olga Ace is a scholar working on Oncology, Cancer Research, Molecular Biology, Rheumatology and Surgery, having authored 8 papers that have together received 816 indexed citations. Recurring topics across this work include Cancer, Lipids, and Metabolism (2 papers), Inflammatory Biomarkers in Disease Prognosis (2 papers), Cancer Immunotherapy and Biomarkers (2 papers), Atherosclerosis and Cardiovascular Diseases (1 paper), Cancer Genomics and Diagnostics (1 paper), Protein Degradation and Inhibitors (1 paper), Cytokine Signaling Pathways and Interactions (1 paper) and Chemical Reactions and Isotopes (1 paper). The work is most often cited by research in Oncology (573 citations), Cancer Research (174 citations), Immunology (139 citations), Biological Psychiatry (13 citations) and Pulmonary and Respiratory Medicine (156 citations). Olga Ace has collaborated with scholars based in Canada, Spain and Slovenia. Frequent co-authors include Francisco Vera-Badillo, Eitan Amir, Arnoud J. Templeton, Alberto Ocaña, Boštjan Šeruga, Ian F. Tannock, Thomas Hermanns, Mustafa Al-Mubarak, Mairéad G. McNamara and Gérald J. Prud’homme. Their work appears in journals such as Experimental and Molecular Pathology, European Journal of Cancer, Cancer Epidemiology Biomarkers & Prevention, Cancer Treatment Reviews and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.